Please select the option that best describes you:

Do you ever treat cervical nodes above the standard supraclavicular field for breast cancer patients?  

For breast cancer patients receiving adjuvant breast/chest wall RT + RNI, do you ever treat cervical nodes above the standard supraclavicular field (e.g., level II/III/V) when CT/MRI/PET is suspicious but biopsy is negative or non-diagnostic?

If yes, do you extend elective coverage and/or boost the dominant node, and what findings push you to treat as oligometastatic M1 instead?

For example, in a patient with ypN3a after NAC/ALND with an enhancing 1.6 cm ipsilateral SCV node and additional suspicious level II/III/V nodes on CT, PET read as reactive; FNA scant/atypical, core/excisional bx deemed too high risk.

What would be your field design and dose/fx recommendations?



Answer from: Radiation Oncologist at Academic Institution
Sign In or Register to read more

Answer from: Radiation Oncologist at Community Practice
Sign In or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign In or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign In or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign In or Register to read more